<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies to the Epstein-Barr virus (EBV)-encoded membrane proteins, LMP2A and LMP2B, were assayed in 540 individuals, including 154 patients with nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, 16 with African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 113 with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, 14 with EBV-carrying gastric <z:mp ids='MP_0002038'>carcinoma</z:mp>, 14 with <z:e sem="disease" ids="C0206186" disease_type="Neoplastic Process" abbrv="">oral hairy leucoplakia</z:e> (HIV+ patients), 37 with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 49 with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> of the head/neck, 19 with <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, 62 with <z:hpo ids='HP_0011010'>chronic</z:hpo> illnesses with EBV titres consistent with re-activations, and 62 healthy controls </plain></SENT>
<SENT sid="1" pm="."><plain>A novel assay, mouse monoclonal enhanced indirect immunofluorescence assay (MIFA) was designed and used to test the sera for antibodies to the LMP2A and 2B proteins, expressed in human keratinocytes </plain></SENT>
<SENT sid="2" pm="."><plain>Antibody to both LMP2A and LMP2B was strikingly specific to NPC </plain></SENT>
<SENT sid="3" pm="."><plain>Virtually <z:hpo ids='HP_0000001'>all</z:hpo> (99 of 101) of the LMP2 antibody positive individuals were NPC patients, 95% of whom had antibodies that reacted both with the LMP2A- and LMP2B-transfected indicator cells, while the remaining 5% reacted only with the LMP2B expressing cells </plain></SENT>
</text></document>